BehindLines

Antibiotics: the EU behind on several 2030 targets

· BehindLines newsroom

The ECDC, the European agency for disease prevention and control, presented on 18 November new reports on antibiotic resistance and on antibiotic consumption in the EU and the countries of the European Economic Area. The figures cited here come from the agency: they are reported by Euronews, which also quotes one of its officials, and by the specialist site CIDRAP, which relies in part on the institution's press release. According to CIDRAP, the agency acknowledges that the EU is still behind on several of its targets for 2030.

More frequent resistant bacteria

According to Euronews, the estimated incidence in the EU of antibiotic-resistant Escherichia coli infections rose by 16.4% between 2019 and 2025, whereas the target was a 10% fall relative to 2019. CIDRAP specifies that these are bloodstream infections caused by E. coli resistant to third-generation cephalosporins. For Klebsiella pneumoniae, a bacterium commonly involved in urinary, respiratory and bloodstream infections, the target was a 5% reduction; incidence reaches 3.75 cases per 100,000 inhabitants in 2025, 72% more than in 2019, according to Euronews. CIDRAP reports the same 72% rise for bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae. Euronews also cites very sharp increases in several countries, including Cyprus. A more favourable sign, reported by CIDRAP: bloodstream infections caused by methicillin-resistant Staphylococcus aureus have fallen by 19% since 2019.

Consumption down, but not enough

CIDRAP says human antibiotic consumption fell by 5% in the EU and the countries of the European Economic Area compared with 2019, far from the 20% reduction aimed for in 2030. The share of first-line antibiotics designated by the World Health Organization stands at 62.5%, against a target of 65%; CIDRAP describes it as slightly up. "We are still behind on several of the EU's 2030 targets," said the ECDC director, Pamela Rendi-Wagner, in a press release cited by CIDRAP.

Prevention and surveillance

According to the ECDC, as reported by Euronews, over 70% of the health toll of antimicrobial resistance at European level is tied to infections picked up through care and caused by multidrug-resistant bacteria, and half of it could be avoided through better prevention and control measures. Christian Giske, head of the agency's section dealing with this resistance and with healthcare-associated infections, cites in this connection, in healthcare facilities, hand hygiene, protective equipment, single rooms for infected patients and cleaning of the environment. According to CIDRAP, Pamela Rendi-Wagner suggests that genomic surveillance, which makes it possible to assess more quickly how resistant bacteria spread, helps to act sooner to stop transmission and to identify where new antibiotics are most needed.

Why it matters

In its rapid risk assessment, cited by CIDRAP, the ECDC warns that the continued rise of carbapenem-resistant Enterobacterales, of which Klebsiella pneumoniae is one, can harm the quality and continuity of care, with a risk judged very high for patients needing care. These figures come from the ECDC's reports and describe trends measured since 2019, not forecasts.

Sources